Equine Recurrent Uveitis: Classification, Etiology, and Pathogenesis
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Equine Uveitis Lauren Hughes, DVM
New England Equine Medical & Surgical Center 15 Members Way · Dover NH 03820 · www.newenglandequine.com · 603.749.9111 Understanding Equine Uveitis Lauren Hughes, DVM One of the most common ocular diseases affecting the horse is a condition known as uveitis. This occurs when inflammation affects the uveal tract of the eye that is composed of the iris, ciliary body and choroid. This inflammation can be caused by a variety of conditions including ocular, systemic or immune mediated disease. Fig 1. Equine Eye Cross-Sectional Anatomy Understanding Uveitis In order to better understand uveitis we need to take a closer look at the causes of this relatively common disease. 1-Ocular- Any condition that affects the eye can lead to uveitis as a secondary complication. This includes trauma, corneal ulcers, intraocular tumors, and cataracts (which cause lens-induced uveitis). 2-Systemic- Many infectious diseases can also predispose a horse to development of uveitis. These diseases can be bacterial, viral, parasitic, or neoplastic, with one of the most recognized being the bacterial disease Leptospirosis. 3-Immune Mediated- The most commonly seen presentation of uveitis is an immune mediated form known as equine recurrent uveitis (ERU) or moon blindness. This disease consists of recurrent episodes of inflammation in which the immune system targets the tissues of the eye. This can be an ongoing and frustrating condition for owners as treatment is not curative and lifelong management is often necessary. This condition has been reported to affect upwards of 25% of the horse population with increased prevalence in certain breeds including Appaloosas, draft horses, and warmbloods.1 It can affect one or both eyes, with chronicity potentially leading to permanent vision deficits or blindness. -
Hypotony Following Intravitreal Silicone Oil Removal in a Patient with a Complex Retinal Detachment with Giant Retinal Tear
Open Access Case Report DOI: 10.7759/cureus.16387 Hypotony Following Intravitreal Silicone Oil Removal in a Patient With a Complex Retinal Detachment With Giant Retinal Tear Ilias Gkizis 1 , Christina Garnavou-Xirou 1 , Georgios Bontzos 1 , Georgios Smoustopoulos 1 , Tina Xirou 1 1. Ophthalmology, Korgialenio-Benakio General Hospital, Athens, GRC Corresponding author: Georgios Smoustopoulos, [email protected] Abstract Postoperative ocular hypotony after silicone oil removal in complex cases of retinal detachment is a complication that can occur in about 20% of cases and can prevent the successful management of retinal detachments. Thus, it is critical to understand the mechanisms of hypotony and the potential interventions that can be done in order to avoid irreversible tissue damage. We present a case of a 35-year-old man who underwent intraocular surgery for removal of silicone oil tamponade following a combined scleral buckling and pars plana vitrectomy (PPV) surgery for a rhegmatogenous retinal detachment associated with a giant retinal tear. On Day 1 after the operation, the patient was found to have hypotony with optic disc edema, chorioretinal folds, and visual acuity of ‘hand movement’ perception. Two weeks postop, the patient’s condition stabilized, with a visual acuity of 0.38 logMAR, an intraocular pressure (IOP) of 12 mmHg, and the absence of macular edema. Categories: Ophthalmology Keywords: hypotony, silicone oil removal, retinal detachment, vitrectomy, giant retinal tear Introduction Ocular hypotony is defined as intraocular pressure (IOP) of 5 mmHg or less. Depending on the duration and time of onset, it can be classified as acute, chronic, transient, or permanent. Whilst acute hypotony is not an uncommon phenomenon following intraocular surgery, it is generally reversible after 10-15 days [1]. -
BLINDNESS in MONGOLISM (DOWN's SYNDROME)*T by J
Br J Ophthalmol: first published as 10.1136/bjo.47.6.331 on 1 June 1963. Downloaded from Brit. J. Ophthal. (1963) 47, 331. BLINDNESS IN MONGOLISM (DOWN'S SYNDROME)*t BY J. F. CULLENt The Wilmer Institute, Johns Hopkins University and Hospital, Baltimore, Maryland IN a previous communication (Cullen and Butler, 1963), the ocular abnor- malities encountered in a survey of 143 mongoloids at the Rosewood State Hospital in Maryland were enumerated, and particular attention was drawn to the occurrence of keratoconus in over 5 per cent. of these patients. The purpose of this paper is to elaborate the incidence and causes of blindness in this same group. In the earlier paper no mention was made of the fact that several blind mongoloids were discovered among those examined, and, as the cause of blindness was in all but one instance associated with cataract or keratoconus, they were classified under these aetiological headings. Earlier surveys of the ocular abnormalities in mongoloids by Ormond (1912), Lowe (1949), Skeller and Oster (1951), and Woillez and Dansaut (1960) do not list any patient as being blind. More recently Eissler and Longenecker (1962) reviewed the ocular findings in 396 mongoloids and, though they made no attempt to compile uncommon ocular conditions, they did not state whether any of this very large number of patients were blind. When one considers that serious ocular conditions occur so com- monly in mongoloids, and that the eyes of such patients might be expected to respond unfavourably to trauma or to surgical insult, it is surprising that http://bjo.bmj.com/ no reference has hitherto been made to the not unexpected occurrence of blindness, particularly if they survive for more than 30 years. -
Leptospirosis Associated Equine Recurrent Uveitis Answers to Your Important Questions What Is Leptospirosis Associated Equine Recurrent Uveitis (LAERU)?
Lisa Dauten, DVM Tri-State Veterinary Services LLC " Leptospirosis Associated Equine Recurrent Uveitis Answers to your Important Questions! What is Leptospirosis Associated Equine Recurrent Uveitis (LAERU)? Let’s start by breaking down some terminology.! Uveitis- inflammation of the uvea. Resulting in cloudiness of the eye, pain, and potential blindness. Also know as “Moon Blindness”. Caused by trauma, infection, or corneal disease.! Uvea- part of the eye containing the iris, ciliary body, and choroid. It keeps the lens of the eye in place, maintains fluid in the eye, and keeps things in the blood from entering the inside of the eye (blood-ocular barrier). ! Recurrent Uveitis- inflammation of the uvea that sporadically reoccurs through out a horses life time. Each time there is a reoccurring episode, the damage to the eye is made worse, eventually leading to permanent damage and potential blindness. ! Leptospirosis- bacteria found in the environment shed in the urine of wildlife and livestock. Horses usually are exposed when grazing pastures or drinking from natural water sources.! LAERU- Recurrent Uveitis in horses caused by Leptospirosis.! What are the clinical signs of Uveitis? Uveitis can come on very suddenly. A lot of times horses present with severe pain in the eye, tearing, squinting, and rubbing face. The eye itself is cloudy, white or blue in color. Sometimes the signs are not as dramatic. The color change of the eye may progress slowly. In these cases, horse owners may mistake the changes for cataracts.! What do I do if I think my horse has Uveitis? Call your veterinarian to request an appointment. -
Equine Recurrent Uveitis Slowly Releases Medication Over a Period of (ERU) Several Years
Treatment ABOUT THE COLLEGE OF VETERINARY MEDICINE Treatment for uveitis in general depends upon the underlying cause as well as Ranked third in the nation among the severity of the symptoms. In most colleges of veterinary medicine by cases, the eye is treated with topical anti- U.S. News & World Report, NC State’s inflammatories and a pupil-dilating agent to College of Veterinary Medicine is a decrease the pain and inflammation. Oral driving force in veterinary innovation. anti-inflammatories such as Banamine® From our leadership in understanding (Flunixin meglumine) are also instituted, and and defining the interconnections in select cases bodily injections of steroids between animal and human health, to may be necessary. While these treatments groundbreaking research in areas like are helpful in subsiding the inflammation equine health, and our commitment to and pain - they’re not ideal for long-term training the next generation of veterinary use. If infectious disease is suspected to health professionals, we are dedicated be the cause, laboratory tests should be to advancing animal and human health performed followed by medical treatment if from the cellular level through entire recommended. ecosystems. If a horse responds favorably to medical therapy, Cyclosporine Implants may be an option for long-term management. This is the surgical implantation of a small Cyclosporine medicated disc that’s placed deep within the pink tissue surrounding the eye (sclera), it Equine Recurrent Uveitis slowly releases medication over a period of (ERU) several years. This medication modifies the reaction to the immune system and reduces NC State Veterinary Hospital Moon Blindness; Periodic Ophthalamia inflammation. -
Aetiology Ofsevere Visual Impairment and Blindness in Microphthalmos 333
332 BritishJournal ofOphthalmology 1994; 78: 332-334 Aetiology of severe visual impairment and blindness in microphthalmos Br J Ophthalmol: first published as 10.1136/bjo.78.5.332 on 1 May 1994. Downloaded from Mark J Elder Abstract a group of patients with microphthalmos who Microphthalmos occupies a spectrum from were bilaterally legally blind. a normal, but small globe, to a globe with multiple anterior and posterior segment abnor- malities. This study examines 54 eyes of 27 Patients and methods patients who had bilateral microphthalmos and All six academic blind schools of the West Bank severe visual impairment or blindness. Con- and Gaza strip were visited prospectively, and genital cataract was the commonest cause of the children examined. 6 There were 241 children severe visual impairment (44%), followed by aged from 5 to 25 years with visual acuities less presumed retinal or optic nerve displasia (30%) than 6/60, irrespective of their ocular diagnosis. and chorioretinal coloboma (22%). Lensec- There were no exclusion criteria. tomy was followed by phthisis bulbi in 3/23 Each school was visited by the 'Outreach' cases and retinal detachment in 2/23 cases. facility of the St John Ophthalmic Hospital, There were no cases of angle closure glau- Jerusalem, which is a well equipped mobile coma. The three clinical conditions associated clinic. A complete history was taken and the with a poor prognosis were cataract, chorio- previous medical records were reviewed. A full retinal coloboma, and a markedly reduced examination was conducted, including best cor- corneal diameter. A corneal diameter of 6 mm rected visual acuity with Sheridan-Gardner test or less was associated with a visual acuity ofno charts, colour vision assessment, visual field perception of light in 81% (21/26) compared testing by confrontation, slit-lamp biomicro- with 4% (1/28) ofthose with larger corneas. -
Immune Responses to Retinal Autoantigens and Peptides in Equine Recurrent Uveitis
Immune Responses to Retinal Autoantigens and Peptides in Equine Recurrent Uveitis Cornelia A. Deeg,1 Bernd Kaspers,1 Hartmut Gerhards,2 Stephan R. Thurau,3 Bettina Wollanke,2 and Gerhild Wildner3 5 PURPOSE. To test the hypothesis that autoimmune mechanisms unclear. Research has focused on the identification of infec- are involved in horses in which equine recurrent uveitis (ERU) tious agents that may induce uveitis, such as bacteria, viruses, develops spontaneously. or parasites, especially on a possible role for Leptospira inter- 6–8 METHODS. Material obtained from horses treated for spontane- rogans as an initiating agent in this process. However, the ous disease by therapeutic routine vitrectomy was analyzed for concept of an infectious factor that exclusively induces and total IgG content and IgG specific for S-Antigen (S-Ag) and maintains the disease is not sufficient to explain certain aspects interphotoreceptor retinoid-binding protein (IRBP). The cellu- of the clinical course and therapeutic approaches. Because of the recurrence of inflammation,5 the positive effect of cortico- lar infiltrate of the vitreous was analyzed by differential counts 2 of cytospin preparations and flow cytometry using equine steroids, and the insufficient therapeutic success of antibiot- lymphocyte-specific antibodies. Antigen-specific proliferation ics, the concept has emerged that the disease is immune assays were performed comparing peripheral blood lympho- mediated. Therefore, ERU is of high value for studying uveitis, because horses represent the only species besides humans in cytes (PBLs) with vitreal lymphocytes by stimulation with S-Ag 9 and several S-Ag– and IRBP-derived peptides. which recurrent uveitis develops spontaneously. -
Ocular Manifestations of Systemic Disease in the Horse
OCULAR MANIFESTATIONS OF SYSTEMIC DISEASE IN THE HORSE L. Chris Sanchez, DVM, PhD, DACVIM Caryn Plummer, DVM, DACVO University of Florida College of Veterinary Medicine, Gainesville, FL USA Overview Many systemic inflammatory diseases in horses have ocular signs, and many ophthalmic diseases (or their treatment) can have or result in systemic signs. Thus, it is important to look at the whole horse when considering treatment plans or prognoses. Though the proceedings are organized by specific manifestations, the talk will be entirely case-based. Ocular Manifestations of Systemic Disease Neonatal sepsis/SIRS The septic foal may seed bacteria to various organs, including the eye. The first sign of septic uveitis is usually a green hue to the iris and anterior chamber as fibrin seeps out of the uveal vasculature. Additional signs of uveitis follow and typically include miosis, globe hypotony (low IOP), aqueous flare, conjunctival and episcleral injection. Occasionally hypopyon and hyphema may develop. Ocular signs may be unilateral or bilateral. Systemic antimicrobial therapy and generalized support are critical to survival. The uveitis must be addressed with symptomatic anti- inflammatory therapy if intraocular scarring is to be avoided. As long as no corneal ulcer is present, topical medical treatment should consist of corticosteroids and atropine. If tolerable, systemic flunixin will benefit the eyes. Occasionally, fibrin will completely fill the anterior chamber and be slow to resorb. If it does not improve rapidly, intracameral tissue plasminogen activator (TPA) may be very helpful to hasten its dissolution. Rhodococcus equi Ocular manifestations of R. equi include uveitis and occasionally hyphema. Signs of uveitis typically include epihora, blepharospasm, photophobia, corneal edema, miosis, aqueous flare and significant accumulations of fibrin in the anterior chamber. -
Onchocerciasis in Ecuador: Ocular Findings in Onchocerca Volvulus Infected Individuals Br J Ophthalmol: First Published As 10.1136/Bjo.79.2.157 on 1 February 1995
British Journal of Ophthalmology 1995; 79: 157-162 157 Onchocerciasis in Ecuador: ocular findings in Onchocerca volvulus infected individuals Br J Ophthalmol: first published as 10.1136/bjo.79.2.157 on 1 February 1995. Downloaded from P J Cooper, R Proaflo, C Beltran, M Anselmi, R H Guderian Abstract which is largely absent from the rain Little is known of the epidemiology and forest.7 clinical picture ofocular onchocerciasis in In the Americas, foci of disease have been South America. A survey of onchocercal described in Mexico, Guatemala, Colombia, eye disease was performed in the hyper- Venezuela, Brazil, and Ecuador. Earlier endemic area of a rain forest focus of reports from Guatemala58 and Venezuela9 onchocerciasis in Esmeraldas Province in indicated ocular pathology attributable to Ecuador. A total of 785 skin snip positive onchocerciasis. The absence of comprehensive individuals from black and Chachi reports on the current status of ocular Amerindian communities were examined. onchocerciasis in any of these foci has made it The blindness rate attributable to difficult to evaluate if blinding onchocerciasis onchocerciasis was 0.4%, and 8.2% were remains a major problem in these regions. visually impaired. Onchocercal ocular The epidemiology of the rain forest focus of lesions were seen in a high proportion of onchocerciasis in Esmeraldas Province of the study group: 33.6% had punctate Ecuador has been extensively studied.'0 keratitis, microfilariae in the anterior Current evidence suggests that the prevalence chamber and cornea were seen in 2890/o and intensity of infection and its geographical and 33.5% respectively, iridocyclitis was boundaries are expanding.11 12 This is because seen in 1.5%, optic atrophy in 5.1%, and of migration of infected individuals and the chorioretinopathy in 28.0%. -
Looking Towards Treatments for Equine Recurent Uveitis
Vet Times The website for the veterinary profession https://www.vettimes.co.uk LOOKING TOWARDS TREATMENTS FOR EQUINE RECURENT UVEITIS Author : Claudia Hartley Categories : Vets Date : May 25, 2009 Claudia Hartley discusses a condition that, according to some estimates, can affect up to 25 per cent of horses, and reveals her opinions on care EQUINE recurrent uveitis (ERU) is an immune-mediated inflammation of one or both eyes that is relapsing and remitting in nature. Prevalence rates have been estimated to be between eight and 25 per cent in a number of studies. The first episode of uveitis typically occurs between four and eight years of age, although not exclusively. Subsequent inflammation flare-ups follow an unpredictable course, as recurrences can be seen weeks or months after quiescence from the first attack. Initially, recurrences were thought to follow the moon cycles and, therefore, the condition was originally known as moon blindness. Horses or ponies that suffer a single episode of uveitis are not considered to have ERU until a relapse is seen – in effect, until they suffer two or more episodes of uveitis. As a relapse may be seen up to two years after the first attack, the risk of developing ERU is very much less if more than two years pass without a second episode. The same is true for unilateral cases; these may become bilateral with time, but that risk is much reduced if two or more years pass without the fellow eye being affected. 1 / 22 Studies have identified a genetic susceptibility associated with equine leucocyte antigen-9 (ELA-9), similar to the association of certain human leucocyte antigen haplotypes and some autoimmune uveitides in humans. -
Symptomatology, Pathology, Diagnosis
I I I t' 0[ I I I' I Symptomatology, pathology, diagnosis Edited by A.A. Buck I l ! @ World Health Organization Geneva The ll/orld Heolth Organization ( ,yHO ) is one of the specialized agencies in realtion- ship with the United Nations. Through this organization, which came into beine in 7948, the public health and medical professions of more than 130 countries exchange their know- ledge and experience and collaborate in an effort to achieve the highest possible level of health throughout the world. ll/HO is concerned primarily with problems that individual countries or territories cannot solve with their own resources-for example, the eradication or control of malaria, schistosomiasis, smallpox, and other communicable diseases, as well as some cardiovascular diseases and cancer. Progress towards better health throughout the world also demands international cooperation in many other activities: for example, setting up international standards for biological substances, for pesticides andfor pesticide spraying equipment ; compiling aninternationalpharmacopoeia ; drawing up and administer- ing the International Heolth Regulations; revising the international lists of diseases and causes of death ; assembling and disseminating epidemiological information ; recommending nonproprietary names for drugs; and promoting the exchange of scientific knowledge. In many parts ofthe world there is need for improvement in maternal and child health, nutrition, nursing, mental health, dental health, social and occupational health, environmental health, public health administrotion, professional education and training, and health education of the public. Thus a large share oJ'the Organization's resources is devotedtogivingassistance and advice in these fields and to making available-often through publications-the latest information on these subjects. -
Ocular Onchocerciasis in Malawi
Brit. J. Ophthal. (1972) 56, 6I7 Br J Ophthalmol: first published as 10.1136/bjo.56.8.617 on 1 August 1972. Downloaded from Ocular onchocerciasis in Malawi A comparative study of 500 patients and 500 controls I. BEN-SIRA AND Y. YASSUR Department of Ophthalmology, Hadassah University Hospital, Jerusalem, Israel Onchocerciasis in Malawi was first described by Gopsill (I939). This eport and the only other one from Malawi (Harvey, I967) dealt with the general picture and the skin manifestations of this disease. Eye complications have not so far been described. A 3-year onchocerciasis survey in Malawi revealed a large endemic focus in the Cholo district. A previous communication dealt with the epidemiological aspects (Ben-Sira, Ticho, and Yassur, I972). The present report describes the clinical picture based on a comparative study of 500 adults with ocular onchocerciasis. The ocular findings in this group were compared with those of another 500 adults from the same area, in whom skin copyright. snips confirmed the absence of infestation with Onchocerca volvulus. Material and methods The Cholo district, one of the richest districts in Malawi, offers favourable conditions for carrying out a survey. The majority of the adult population work on the tea estates and earn monthly wages. The soil is very fertile and malnutrition is rare. Two hospitals and several dispensaries http://bjo.bmj.com/ cover the whole area. In two large projects, one for leprosy and the other for tuberculosis, the majority of the infected population has been discovered and treated. There are sufficient data concerning the type and prevalence of diseases in this area for it to be possible to establish the clinical picture of ocular onchocerciasis after the exclusion of other factors.